PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
It is the first autotaxin inhibitor to be investigated in cancer patients
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The investment will catalyse various components of the IndiaAI Mission
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
ANVISA issues CGMP to Concord Biotech’s Unit I
Sharma joined the Morepen Lab in 2004
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Acquisition of exclusive commercialization rights for European markets
Subscribe To Our Newsletter & Stay Updated
